Oclacitinib Maleate

Spécifications

1208319-27-0Numéro CAS

962-495-8Numéro CE

(Z)-but-2-enedioic acid;N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamideNom IUPAC

C19H27N5O6SFormule chimique

453.5 g/molMasse molaire

OCLACITINIB MALEATE; UNII-VON733L42A; VON733L42A; PF-03394197-11; PF 03394197-11; OCLACITINIB MALEATE (EMA EPAR: VETERINARY); N-Methyl(trans-4-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)cyclohexyl) methanesulfonamide (2Z)-2-butenedioate; N-Methyl[trans-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexyl] methanesulfonamide (2Z)-2-butenedioate; RefChem:58073; 1208319-27-0; 1640292-55-2; Oclacitinib (maleate); Apoquel; Oclacitinib maleate [USAN]; (Z)-but-2-enedioic acid;N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide; MFCD30533388; N-methyl-1-(trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide maleate(1:x); Cis-Oclacitinib Maleate; Oclacitinib?maleate; Oclacitinib maleate (USAN); N-methyl-1-((1r,4r)-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide maleate; Oclacitinib maleate?; Oclacitinib(maleate); PF-03394197 maleate; SCHEMBL260868; orb2647042; CHEMBL2105739; OCLACITINIB MALEATE [MI]; SCHEMBL19205843; SCHEMBL29367336; GLXC-15415; HMS5086E09; EX-A3658; HY-13577A; s8195; AKOS040759049; CCG-269269; CS-7611; AC-32980; BS-44681; SY347016; D10142; D84061; F812105; Q27291934; Cyclohexanemethanesulfonamide, N-methyl-4-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4- ylamino)-, trans-, (2Z)-2-butenedioate (1:?); maleic acid;N-methyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide; N-Methyl-1-[trans-4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide MaleateSynonymes